107
Views
0
CrossRef citations to date
0
Altmetric
Review

Revisiting transdermal scopolamine for postoperative nausea and vomiting

, , , , &
Pages 35-44 | Published online: 13 Aug 2015

References

  • Mavridou P, Dimitriou V, Manataki A, Arnaoutoglou E, Papadopoulos G. Patient’s anxiety and fear of anesthesia: effect of gender, age, education, and previous experience of anesthesia. A survey of 400 patients. J Anesth. 2013;27(1):104–108.
  • Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999;89(3):652–658.
  • Carvalho B, Cohen SE, Lipman SS, Fuller A, Mathusamy AD, Macario A. Patient preferences for anesthesia outcomes associated with cesarean delivery. Anesth Analg. 2005;101(4):1182–1187.
  • Kapur PA. The big “little problem”. Anesth Analg. 1991;73(3):243–245.
  • Apfel CC, Philip BK, Cakmakkaya OS, et al. Who is at risk for postdischarge nausea and vomiting after ambulatory surgery? Anesthesiology. 2012;117(3):475–486.
  • Kolodzie K, Apfel CC. Nausea and vomiting after office-based anesthesia. Curr Opin Anaesthesiol. 2009;22(4):532–538.
  • Odom-Forren J, Hooper V, Moser DK, et al. Postdischarge nausea and vomiting: management strategies and outcomes over 7 days. J Perianesth Nurs. 2014;29(4):275–284.
  • Obrink E, Jildenstal P, Oddby E, Jakobsson JG. Post-operative nausea and vomiting: update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery. Int J Surg. 2015;15C:100–106.
  • Fabling JM, Gan TJ, El-Moalem HE, Warner DS, Borel CO. A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. Anesth Analg. 2000;91(2):358–361.
  • Lipp A, Kaliappan A. Focus on quality: managing pain and PONV in day surgery. Curr Anaesth Crit Care. 2007;18:200–207.
  • Feng PH, Chu KS, Lu IC, et al. Haloperidol plus ondansetron prevents postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Taiwan. 2009;47(1):3–9.
  • Apfel C, Laara E, Koivuranta M, Greim C, Rower N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anaesthesiology. 1999;91:693–700.
  • Gan TJ, Diemunsch P, Habib AS, Society for Ambulatory Anesthesia, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.
  • Fortier J, Chung F, Su J. Unanticipated admission after ambulatory surgery – a prospective study. Can J Anaesth. 1998;45:612–619.
  • Gold B, Kitz D, Lecky J, Neuhaus J. Unanticipated admission to the hospital following ambulatory surgery. J Am Med Assoc. 1989;262:3008–3010.
  • Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92:958–967.
  • Tramer M. Strategies for postoperative nausea and vomiting. Best Practice and Research. Clin Anaesthesiol. 2004;18:693–701.
  • Pergolizzi JV, Raffa R, Taylor R. Prophylaxis of postoperative nausea and vomiting in adolescent patients: a review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine. J Drug Deliv. 2011;2011:426813.
  • Koivuranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anaesthesia. 1997;52:443–449.
  • Sinclair D, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology. 1999;91:109–118.
  • Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742–753.
  • Zhang L, Wang J, Chen C. Clinical studies of the relationship between the complication of cervicofacial rhytidectomy postoperative nausea and vomiting and different rhytidectomy sites. J Craniofac Surg. 2015;26(2):e168–e172.
  • Hernandez Mateo MM, Martinez-Lopez I, Hernando-Rydings M, Revuelta-Suero S, Marques de Marino P, Serrano Hernando FJ. Systematic nasogastric tube in aortic surgery: is it necessary? Ann Vasc Surg. 2015;29(4):786–791.
  • Lichtor JL. Nausea and vomiting after surgery: it is not just postoperative. Curr Opin Anaesthesiol. 2012;25(6):673–679.
  • Le TP, Gan TJ. Update on the management of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery. Anesthesiol Clin. 2010;28(2):225–249.
  • Odom-Forren J, Jalota L, Moser DK, et al. Incidence and predictors of postdischarge nausea and vomiting in a 7-day population. J Clin Anesth. 2013;25(7):551–559.
  • Parra-Sanchez I, Abdallah R, You J, et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anaesth. 2012;59(4):366–375.
  • Wesmiller SW, Bender CM, Sereika SM, et al. Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery. Oncology Nurs Forum. 2014;41(2):195–202.
  • Rowley M, Brown T. Postoperative vomiting in children. Anaesth Intensive Care. 1982;10:309–313.
  • Apfel CC, Korttila K, Abdalla M, IMPACT Investigators, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–2451.
  • Kranke P, Apefel CC, Papenfuss T, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting. A systematic review and results of original data. Acta Anaesthesiol Scand. 2001;45:160–166.
  • Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology. 2005;102:1094–1100.
  • Tramer MR, Moore A, McQuay H. Meta-analytic comparison of prophylactic antiemetic efficacy for postoperative nausea and vomiting: propofol anaesthesia vs omitting nitrous oxide vs total iv anaesthesia with propofol. Br J Anaesth. 1997;78:256–259.
  • Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. 2002;88(5):659–668.
  • Roberts G, Bekker T, Carlsen H, Moffatt C, Slattery P, McClure A. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg. 2005;101:1343–1348.
  • Scuderi P, James R, Harris L, Mims GR. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg. 2000;91:1408–1414.
  • Apfel CC, Meyer A, Orhan-Sungur M, Jalota L, Whelan RP, Jukar-Rao S. Supplemental intravenous crystalloids for the prevention of postoperative nausea and vomiting: quantitative review. Br J Anaesth. 2012;108(6):893–902.
  • Bailey PL, Streisand JB, Pace NL, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology. 1990;72(6):977–980.
  • Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2002;95(1):133–143.
  • Apfel CC, Zhang K, George E, et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther. 2010;32(12):1987–2002.
  • Semple P, Madej TH, Wheatley RG, Jackson IJ, Stevens J. Transdermal hyoscine with patient-controlled analgesia. Anaesthesia. 1992;47(5):399–401.
  • Harris SN, Sevarino FB, Sinatra RS, Preble L, O’Connor TZ, Silverman DG. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia. Obstet Gynecol. 1991;78(4):673–677.
  • White PF, Tang J, Song D, et al. Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms. Anesth Analg. 2007;104(1):92–96.
  • Antor MA, Uribe AA, Erminy-Falcon N, et al. The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting. Front Pharmacol. 2014;5:55.
  • Samad A, Ullah Z, Alam MI, Wais M, Shams MS. Transdermal drug delivery system: patent reviews. Recent Pat Drug Deliv Formul. 2009;3(2):143–152.
  • Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. 2005;27(5):655–665.
  • Harnett MJ, O’Rourke N, Walsh M, Carabuena JM, Segal S. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesth Analg. 2007;105(3):764–769.
  • Honkavaara P, Pyykko I, Rutanen EM. Increased incidence of retching and vomiting during periovulatory phase after middle ear surgery. Can J Anaesth. 1996;43(11):1108–1114.
  • Einarsson JI, Audbergsson BO, Thorsteinsson A. Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial. J Minim Invasive Gynecol. 2008;15(1):26–31.
  • DailyMed.com. Transderm Scop, Scopolamine Patch, Extended Release. Drug Label Information; 2014. Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e5dab9c-755b-460e-afe2-1ddfc4acfd96. Accessed March 24, 2015.
  • Lin CH, Lung HL, Li ST, Lin CY. Delirium after transdermal scopolamine patch in two children. J Neuropsychiatry Clin Neurosci. 2014;26(2):E01–E02.
  • Norton JA, Khabiri B, Arbona FL, Kover AJ. Possible central anticholinergic syndrome following transdermal scopolamine in an ambulatory surgery patient. Can J Anaesth. 2011;58(12):1149–1150.
  • Jenerowicz D, Polanska A, Olek-Hrab K, Silny W. Skin hypersensitivity reactions to transdermal therapeutic systems – still an important clinical problem. Ginekol Pol. 2012;83(1):46–50.
  • Green MS, Green P, Malayaman SN, Hepler M, Neubert LJ, Horrow JC. Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):716–722.
  • Gan TJ, Sinha AC, Kovac AL, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg. 2009;108(5):1498–1504.
  • Sah N, Ramesh V, Kaul B, Dalby P, Shestak K, Vallejo MC. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. J Clin Anesth. 2009;21(4):249–252.
  • Jones S, Strobl R, Crosby D, Burkard JF, Maye J, Pellegrini JE. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron. AANA J. 2006;74(2):127–132.
  • Lee JS, Costantino M, McCullough MF, et al. Transdermal scopolamine patch with odansetron for the control of nausea after uterine artery embolization compared with odansetron alone: results of a randomized placebo-controlled trial. J Vasc Interv Radiol. 2010;21(7):1018–1023.
  • Lee HK, Lee JH, Chon SS, Ahn EK, Kim JH, Jang YH. The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery. Korean J Anesthesiol. 2010;58(1):50–55.
  • Horimoto Y, Tomie H, Hanzawa K, Nishida Y. Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery. Can J Anaesth. 1991;38:441–444.
  • Honkavaara P, Saarnivaara L, Klemola UM. Effect of transdermal hyoscine on nausea and vomiting after surgical correction of prominent ears under general anaesthesia. Br J Anaesth. 1995;74(6):647–650.
  • Delgado-Charro MB, Guy RH. Effective use of transdermal drug delivery in children. Adv Drug Deliv Rev. 2014;73:63–82.
  • Eberhart LH, Geldner G, Kranke P, et al. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg. 2004;99(6):1630–1637.
  • Kranke P, Eberhart LH, Toker H, Roewer N, Wulf H, Kiefer P. A prospective evaluation of the POVOC score for the prediction of postoperative vomiting in children. Anesth Analg. 2007;105(6):1592–1597.
  • Habib A, Gan T. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J Clin Anesth. 2005;17:62–65.
  • Pergolizzi JV, Pappagallo M, LeQuang J, Labhsetwar S, Taylor R. New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting. Hosp Pract (1995). 2014;42(1):65–74.